Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Sinclair currently holds 4,200 shares of SOLENO THERAPEUTICS INC (SLNO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Sinclair has been a net buyer of SLNO stock. They have purchased $33.8M and sold $0 worth of shares.
Andrew Sinclair's most recent insider trade was on Jun 21, 2026, when they sold 4,200 shares at $0.00 per share.
Andrew Sinclair serves as Executive at SOLENO THERAPEUTICS INC (SLNO). They have executed 26 insider transactions totaling $33.8M over their tenure at the company.
Andrew Sinclair holds the position of Executive at SOLENO THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Andrew Sinclair has shown a buying trading pattern, with $33.8M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew Sinclair was on Jul 1, 2022, when they sold $72.3M worth of SRRA shares. This transaction involved 1,314,127 shares at $55.00 per share.
Andrew Sinclair currently owns 4,200 shares of SOLENO THERAPEUTICS INC (SLNO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Sinclair's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Sinclair has 26 Form 4 filings on record as an insider at SOLENO THERAPEUTICS INC.
Set alerts for Andrew Sinclair and 40,000+ other insiders.